Back
Neurogene Quote, Financials, Valuation and Earnings
Sponsored
NGNE
Sponsored
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Sell
4
NGNE
Neurogene
Last Price:
15.32
Seasonality Move:
43.35%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.Neurogene Price Quote
$15.32
-0.01 (-11.09%)
(Updated: November 21, 2024 at 5:18 AM ET)
Neurogene Key Stats
Sell
4
Neurogene (NGNE)
is a Sell
Day range:
$15.28 - $17.45
52-week range:
$12.49 - $74.49
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.66%
Volume:
796.4K
Avg. volume:
397.8K
1-year change:
16.14%
Market cap:
$257.5M
Revenue:
$0
EPS:
$-20.01
How Much Does Neurogene Make?
Data Unavailable
Is Neurogene Growing As A Company?
Data Unavailable
Neurogene Stock Price Performance
What Is Neurogene 52-Week High & Low?
Neurogene Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Neurogene?
Is Neurogene Cash Flow Positive?
Neurogene Return On Invested Capital
Data Unavailable
Neurogene Earnings Date & Stock Price
-
What Is Neurogene's Stock Price Today?
A single share of NGNE can be purchased today for 15.33 -
What Is Neurogene’s Stock Symbol?
Neurogene trades on the nasdaq under the ticker symbol: NGNE -
When Is Neurogene’s Next Earnings Date?
The next quarterly earnings date for Neurogene is scheduled on March 18, 2025 -
When Is NGNE's next ex-dividend date?
Neurogene's next ex-dividend date is November 21, 2024 -
How To Buy Neurogene Stock?
You can buy Neurogene shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Neurogene Competitors
Neurogene Dividend Yield
-
What Is NGNE Dividend Yield?
Neurogene’s dividend yield currently is 0% -
What Is Neurogene’s Payout Ratio?
Neurogene’s payout ratio is 0% -
When Did Neurogene Last Pay A Dividend?
The latest dividend pay date is November 21, 2024 -
What Is Neurogene’s Dividend Per Share?
Neurogene pays a dividend of $0.00 per share
Neurogene Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 62.00 |
Upside from Last Price: | 304.44% |